首页> 外文会议>International College of Surgeons >Non-Antithrombotic Treatment of Acute Coronary Syndromes: Role of Beta-Blockers, Calcium Channel Blockers,and Nitrates
【24h】

Non-Antithrombotic Treatment of Acute Coronary Syndromes: Role of Beta-Blockers, Calcium Channel Blockers,and Nitrates

机译:急性冠状动脉综合征的非抗抗血栓形成:β-封锁剂,钙通道阻滞剂和硝酸盐的作用

获取原文

摘要

Beta-blockers, calcium channel blockers, and nitrates are anti-ischemic agents with proven efficacy in relieving angina in patients with coronary artery disease. Although these agents differ in their mechanisms of action, they increase coronary blood flow and reduce myocardial oxygen demand. These effects can be expected to be of benefit in acute coronary syndromes like unstable angina (UA) and acute myocardial infarction (AMI). However, relieving pain is only a minor goal in the treatment of unstable coronary syndromes, the major goals being the treatment of myocardial ischemia, the preservation of left ventricular function, and the improvement of prognosis.In this chapter we summarize the extent of the available evidence on the effect of these agents on prognosis, especially the occurrence of myocardial infarction and mortality, in patients with AMI and UA.
机译:β-阻滞剂,钙通道阻滞剂和硝酸盐是抗缺血剂,在患有冠状动脉疾病患者中缓解心绞痛的疗效。虽然这些药剂在其作用机制中不同,但它们增加了冠状​​动脉血流并减少了心肌需氧量。这些效果可以预期在急性冠状动脉综合征(如不稳定的心绞痛(UA)和急性心肌梗死(AMI)中有益。然而,缓解疼痛只是治疗不稳定冠状动脉综合征的轻微目标,主要目标是治疗心肌缺血,保存左心室功能,以及预后的改善。本章总结了可用的程度有关这些药物对预后的影响,特别是AMI和UA患者患者患者患者的血肿和死亡率的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号